AbbVie Bets Big on Immunology Future with $10.9 Billion Acquisition of Apogee Therapeutics
By Elsie Kamsiyochi Pharmaceutical giant has announced a landmark $10.9 billion acquisition of , marking its largest takeover in more than five years and reinforcing its commitment to expanding its leadership in immunology treatments. The deal, unveiled on …